Solara Active Pharma Sciences

480.75
-0.50
(-0.10%)
Market Cap
1,733.30 Cr
EPS
-157.62
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
882.80
52 Week Low
366.70
PB Ratio
1.59
Debt to Equity
0.83
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,677.60
#1 4,02,512.40
35.10
#1 49,887.20
12.06
#1 9,648
-18.99
42.28
6,612.00
1,75,527.80
80.12
8,184.00
0.89
1,600
23.05
63.47
1,465.70
1,18,372.10
22.44
26,520.70
14.17
4,155
30.28
44.20
3,174.70
1,07,446.30
55.71
10,785.70
11.59
1,656
10.91
44.55
1,251.20
1,04,407.10
#1 18.47
28,905.40
12.36
5,578
21.14
67.52
2,467.70
1,01,812.00
51.37
10,615.60
19.57
1,942
-10.91
48.86
930.00
93,579.80
20.04
19,831.50
13.82
3,831
-0.19
63.14
1,957.70
89,377.00
27.25
20,141.50
#1 19.94
1,936
#1 112.49
43.05
1,147.80
66,664.40
19.29
29,559.20
17.55
3,169
-0.50
43.00
30,455.00
64,714.70
45.75
6,097.20
10.80
1,201
27.83
50.48
Forecast
Actual
Growth Rate
Revenue Growth
-11.74 %
Net Income Growth
2,442.60 %
Cash Flow Change
-30.32 %
ROE
3,990.54 %
ROCE
-1,472.62 %
EBITDA Margin (Avg.)
-165.04 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
303
344
360
392
335
356
350
309
353
404
435
454
412
405
105
367
337
342
402
385
354
426
212
301
364
347
302
279
Expenses
263
295
294
321
267
283
266
247
265
300
321
345
315
330
199
349
318
311
350
332
333
393
436
412
322
286
243
228
EBITDA
40
49
66
71
68
73
84
62
88
104
114
109
97
75
-94
18
20
31
52
53
21
34
-224
-111
43
62
59
51
Operating Profit %
13 %
14 %
17 %
17 %
19 %
19 %
23 %
17 %
24 %
25 %
25 %
22 %
22 %
18 %
-98 %
3 %
4 %
8 %
11 %
13 %
5 %
8 %
-106 %
-38 %
12 %
18 %
19 %
17 %
Depreciation
19
19
21
23
23
24
24
24
26
28
27
27
28
28
28
28
28
29
28
27
26
26
26
25
25
25
25
24
Interest
18
20
23
22
19
20
19
20
20
19
21
25
19
17
18
22
23
22
24
22
25
24
25
31
31
28
27
29
Profit Before Tax
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
-31
-31
-19
1
5
-29
-17
-275
-167
-14
8
8
-2
Tax
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
-33
-15
-9
0
1
-10
0
0
89
0
0
0
0
Net Profit
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
2
-17
-10
0
4
-19
-17
-275
-255
-14
8
8
-2
EPS in ₹
0.23
3.47
8.96
10.17
10.29
11.21
16.00
6.78
15.75
19.21
18.47
15.57
13.95
8.27
-38.93
0.53
-4.56
-2.77
0.12
1.05
-5.43
-4.77
-72.07
-70.93
-3.50
2.54
2.03
-0.93

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,822
1,960
2,154
2,614
2,945
2,899
2,351
Fixed Assets
1,086
1,218
1,397
1,382
1,356
1,364
1,268
Current Assets
608
648
672
1,058
1,239
1,188
801
Capital Work in Progress
72
40
41
88
239
239
256
Investments
1
0
0
0
0
2
2
Other Assets
663
702
716
1,144
1,350
1,295
825
Total Liabilities
1,822
1,960
2,154
2,614
2,945
2,899
2,351
Current Liabilities
738
656
730
789
1,063
1,101
1,243
Non Current Liabilities
315
344
333
232
354
296
172
Total Equity
769
960
1,090
1,593
1,527
1,502
937
Reserve & Surplus
739
826
963
1,553
1,489
1,464
898
Share Capital
25
26
27
36
36
36
36

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
32
30
-20
142
-151
-38
-0
Investing Activities
-86
-113
-359
-106
-243
-81
-4
Operating Activities
49
166
242
156
-242
156
109
Financing Activities
68
-23
97
93
334
-113
-106

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
44.11 %
41.07 %
41.07 %
39.51 %
39.71 %
40.40 %
40.40 %
40.40 %
40.97 %
39.31 %
37.19 %
30.49 %
30.49 %
37.27 %
37.27 %
37.23 %
37.94 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.80 %
14.00 %
14.25 %
14.67 %
14.63 %
DIIs
3.72 %
6.18 %
5.55 %
5.38 %
3.39 %
2.85 %
2.56 %
3.01 %
2.22 %
1.75 %
1.75 %
1.71 %
2.97 %
2.83 %
3.38 %
3.19 %
2.61 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
14.76 %
14.35 %
13.84 %
16.36 %
17.41 %
16.61 %
17.28 %
16.54 %
16.23 %
18.06 %
19.84 %
20.95 %
20.15 %
19.61 %
18.83 %
21.93 %
23.07 %
Others
37.41 %
38.40 %
39.53 %
38.73 %
39.48 %
40.15 %
39.76 %
40.04 %
40.58 %
40.88 %
41.22 %
46.84 %
30.59 %
26.29 %
26.28 %
22.98 %
21.74 %
No of Share Holders
58,907
67,197
65,449
73,000
77,228
82,710
83,319
79,149
76,325
75,417
74,473
72,918
73,912
78,617
71,882
83,148
75,791

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 5 2 7 0.00 3 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.22 0.16 1.14 0.00 0.88 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 482.35 576.30
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 652.85 678.80
21 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Oct 2024 748.90 809.60
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 694.40 736.35
15 May 2024 RIGHTS Rights
1:3
15 May 2024 465.01 503.40
20 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
18 Aug 2021 1,484.58 1,564.11
25 Mar 2017 CHANGE OF NAME Change Of Name
NA
25 Mar 2017 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance3 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2025
Appointment Of Internal Auditors Secretarial Auditor And Reappointment Of Cost Auditor.May 15, 2025
Appointment of Company Secretary and Compliance OfficerMay 15, 2025
Announcement under Regulation 30 (LODR)-RetirementMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
Statement Of Deviation And VariationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31 2025May 15, 2025
Audited Financial Results For The Quarter And Year Ended March 31 2025May 15, 2025
Announcement Under Regulation 30 - Press ReleaseMay 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
Board Meeting Intimation for Board Meeting IntimationMay 07, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 07, 2025
Board Meeting Outcome for Board Meeting Outcome For The Rights Issue Committee Meeting - Receipt Of First Call MoneyMay 06, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressMay 05, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMay 05, 2025
Incorporation Of Wholly Owned Subsidiary CompanyApr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 09, 2025
Notice On The First Call Money Of The Rights Equity Shares.Apr 09, 2025
Board Meeting Outcome for Outcome Of The Rights Issue Committee Meeting_Solara Active Pharma Sciences LimitedApr 02, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 02, 2025
Board Meeting Intimation for Rights Issue Committee Meeting To Approve The Notice Of First Call To Be Sent To The Eligible Shareholders.Mar 26, 2025
Closure of Trading WindowMar 26, 2025
Record Date For The Purpose Of Making First Call For Rights Issue Equity SharesMar 26, 2025
Board Meeting Outcome for Intimation Under Regulation 30 And 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 26, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 21, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 20, 2025
Board Meeting Intimation for Rights Issue Committee Meeting For Making The First Call Of The Shares Issued On Rights Basis By The Company.Mar 20, 2025
Grant Of ESOP OptionsFeb 21, 2025
Closure Of Wholly Owned SubsidiaryFeb 21, 2025
Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorFeb 21, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 21, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 21, 2025
Board Meeting Outcome for Solara Active Pharma Sciences Limited Has Informed The Exchange Regarding Board Meeting Held On February 21 2025 Interalia To Consider Changes In Management And Directorate CFeb 21, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 10, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Integrated Filing (Financial)Jan 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 24, 2025
Statement Of Deviation And VariationJan 24, 2025
Financial ResultsJan 24, 2025
Announcement Under Regulation 30 (LODR) - UpdateJan 24, 2025

Technical Indicators

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Aditya Birla Sun Life Mid Cap Direct Fund-Growth
101729
0.09%
-0.03%
-0.03%
Apr 2025
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
65000
0.32%
0.02%
0.02%
Apr 2025
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
420000
0.09%
-0.01%
-0.01%
Apr 2025
Bandhan BSE Healthcare Index Fund Direct-Growth
438
0.12%
-0.01%
-0.01%
Apr 2025